ArthroCare Corp.

David F. Fitzgerald became a Director of the Company in April 2003 and President and Chief Executive Officer in February 2009. Mr. Fitzgerald spent twenty-five years in management positions at Pfizer, Inc., serving as President and Chief Executive Officer of its Howmedica division during his last fifteen years with the company, prior to retiring in 1996. He also serves on the Board of Directors of Orthovita, Inc and on the Board of Advisors of Sandvik MedTech, a contract manufacturer in the medical devices area. He served on the Board of Directors of LifeCell Corporation from 2001 until the company was acquired by Kinetic Concepts, Inc. in 2008. He holds a B.S. from American International College and M.B.A. from New York University.

Jack Giroux joined ArthroCare in 2002 and is responsible for managing the company's surgical business units. Most recently, he was executive vice president of commercial operations for Guava Technologies Inc. Prior to this position, Giroux held senior-level positions at ReSound Corp. As president of ReSound North America, he was responsible for increasing sales and profits of the company's Hearing Health Care business and managing the unit's marketing, sales, finance, manufacturing and quality functions. As vice president of sales and marketing, Giroux built ReSound's sales and marketing department, managed customer service and technical support, supervised professional training, and helped prepare the company for an initial public offering. Giroux also served as vice president of marketing for Allergan Optical, facilitating programs that significantly increased the sales and market share of its Contact Lens Solutions business. In addition, Giroux was vice president, management supervisor for Ogilvy & Mather Advertising, where he directed worldwide advertising activities for G.D. Searle's launch of the NutraSweet brand sweetener.

Sten I. Dahlborg joined our Company in May 1998 as Managing Director, ArthroCare Europe AB. In May 2003, Mr. Dahlborg was named Vice President and General Manager, ArthroCare Europe. Prior to joining the Company, Mr. Dahlborg was Business Director of Medtronic Synectics from 1996 to 1998. From 1994 to 1996 Mr. Dahlborg was President of Synectics Medical, Inc. and held various sales and marketing positions with Synectics from 1991 to 1994. Mr. Dahlborg holds a M.Sc. degree in Engineering Physics from Chalmers University of Technology, Gothenburg, Sweden.

Brian Simmons is a Certified Public Accountant and joined ArthroCare as Vice President, Finance in February 2007 where he manages the finance and information system functions for ArthroCare. Prior to joining ArthroCare, he served as controller for the Security business unit of General Electric Company beginning in 2003 where he was responsible for the accounting function and financial reporting to General Electric Corporate. He began his career in 1998 as an auditor with PricewaterhouseCoopers LLP, working on audit and attest engagements in a variety of industries. Mr. Simmons holds a bachelor of science in business administration from Trinity University and a master’s degree in accounting from Trinity University.

Jean Woloszko joined ArthroCare in 1998 as medical director and was promoted to vice-president Research and Development in 1999 and to his current position in 2003. Prior to joining ArthroCare, he served in various medical, research and academic positions in Europe and in the US. He also was principal manager of research and medical affairs at Medtronic. He holds a doctorate in bioengineering from the University of Illinois, Chicago and received his medical degree from the Université de Montpellier (France). He also holds a certification in Biomechanics and in Rehabilitation Medicine.

Richard Rew joined ArthroCare in 2006 as vice president of legal affairs. He joins ArthroCare from Activant Solutions Inc., a software and services company. Rew served as general counsel of Activant beginning in 2000 and was most recently vice president, general counsel & secretary. Prior to Activant, he served as general counsel for publicly traded EZCORP Inc. from 1996 to 2000. Rew is a member of the State Bar of Texas.

Ross Beam joined ArthroCare in January 2003 and is responsible for sales throughout North and South America. After joining ArthroCare as director of sales, he was appointed vice president, sales in November 2004. Prior to joining ArthroCare, Mr. Beam held a variety of sales management and marketing positions in over 15 years of medical device experience with Axya Medical, Innovasive Devices, Smith & Nephew and Acufex Microsurgical. Mr. Beam holds a bachelor of science degree from the University of Cincinnati.

Mr. Davison has more than fifteen years experience in the medical device industry, most recently as the Director of Research and Development for ArthroCare Corporation. Prior to ArthroCare, Mr. Davison held several engineering and product development positions at Medtronic, Inc. and Baxter International, Inc.

Merlene is a mechanical design engineer with over 10 years experience designing medical systems at GE, Phillips, and Arthrocare. She also has significant experience designing power systems. She holds an MS in Mechanical Engineering from Stanford University, and a BS in Mechanical Engineering from Boston University.

James C. Foster is Chairman of the Board, President and Chief Executive Officer of Charles River Laboratories, a provider of essential products and services that help accelerate the drug development process. Since beginning his career at Charles River in 1976, Mr. Foster has held a variety of positions including: Vice President of Administration and General Counsel, President of Charles River Biotechnical Services, and Executive Vice President, Charles River. Mr. Foster was named President in 1991, Chief Executive Officer in 1992, and Chairman in 2000. Under Mr. Foster’s leadership, through both acquisition and organic growth, Charles River expanded its position as a leading provider of research models and services. Today, the Company offers a unique portfolio of products and services required to take a novel drug therapy from discovery through proof of concept. Mr. Foster’s focus on execution and exceeding client expectations was the driving force behind the Company’s largest expansion in history, developing approximately one million square feet of new real estate from 2007-2009. This strategic initiative enhanced the Company’s global footprint by providing state-of-the-art facilities conveniently located to clients world wide, including a new site in China. Mr. Foster was named one of the New England region’s 2007 Entrepreneurs of the Year by Ernst & Young LLP. He holds the position of Chairman of the Advisory Board for the Entrepreneurial Leadership Program at Tufts University, and is a member of the Visiting Committee, and the North American Executive Board of Massachusetts Institute of Technology (MIT) Sloan School of Management. Mr. Foster serves as a member of the Board of Trustees of DeCordova Museum and Sculpture Park and of the Institute of Contemporary Art, Boston. He is also a member of the Visiting Committee for Contemporary Art at the Museum of Fine Arts, Boston. He has been a guest lecturer at MIT, Brandeis University, Northeastern University, Tufts University, and The Olin School of Business at Washington University. Mr. Foster holds a B.A. degree in Psychology from Lake Forest College, an M.S. degree from MIT and a J.D. degree from Boston University School of Law. He is a member of both the Massachusetts and American Bar Associations.

James G. Foster became a director of the Company in August 2002. From December 1994 until he retired in June 2001, Mr. Foster was Vice President and General Manager of Medtronic Heart Valves, a division of Medtronic, Inc., a medical device company. From February 1984 to December 1994, Mr. Foster held various positions at Medtronic including Vice President of Cardiac Surgery Sales & Strategic Planning in 1994, Vice President and General Manager of Medtronic Neurological Implantables from 1992 to 1994, Vice President and General Manager of Medtronic Interventional Vascular from 1990 to 1992 and Vice President and General Manager of Medtronic Blood Systems from 1983 to 1989. Since March 1995, Mr. Foster has also been a director of LifeCell Corporation, a company engaged in the development and commercialization of biological products to repair and replace damaged human tissue. Since July 2003, Mr. Foster has been a directors of Neothermia Corp., a company engaged in the development and marketing of a unique, state-of-the-art breast biopsy technology and products. Mr. Foster also serves on the boards of the International Heart Institute of Montana Foundation and Life Coaches. He holds a master's degree in management from the Sloan School at MIT and a B.S. from St. Joseph's University in Philadelphia.

Michael Baker joined ArthroCare in July 1997 as president and chief executive officer. Baker has led the company to successfully leverage its patented Coblation technology across many soft tissue surgical markets. He was previously vice president, general manager of the Coronary Vascular business unit at Medtronic, Inc., a leading medical technology company specializing in implantable and invasive therapies. During his eight-year tenure with Medtronic, Baker held a variety of positions including vice president of Medtronic's Venture Division and director of corporate development and strategic planning. Prior to joining Medtronic, he was a management consultant at the Carroll Group. Baker holds an undergraduate degree from the United States Military Academy at West Point and a master's degree in business administration from the University of Chicago.

Peter L. Wilson was appointed to the Company's Board of Directors in December 2001 and was appointed as the lead independent director in November 2002. Mr. Wilson currently serves on the board of directors of ArthroCare Corporation. Mr. Wilson was President and Chief Executive Officer of Patient Education Systems from 1995 to 1998. Between 1992 and 1994, Mr. Wilson was an independent consultant in healthcare business development and marketing. From 1972 to 1992, Mr. Wilson worked for Proctor & Gamble / Richardson Vicks, where he held various positions as President of Richardson Vicks, Vice President/General Manager of Proctor & Gamble Vicks Healthcare, President/General Manager of the Vidal Sassoon Division and President/General Manager of the Personal Care Division. Mr. Wilson holds a B.A. from Princeton University and a M.B.A. in Marketing from Columbia University.

Terrence Geremski became a director of the Company in December 2006. From 2001 to 2006, Mr. Geremski was senior vice president of Finance and chief financial officer of Carpenter Technology Corporation, an international manufacturer and distributor of specialty metals and engineered products. From 1992 to 2000, Mr. Geremski served as executive vice president and chief financial officer as well as a Board member of Guilford Mills, Inc., a North Carolina-based international textile company. He also served as vice president and controller and various other management positions for Varity Corporation from 1979-1991. Mr. Geremski has also been an auditor and tax manager with Price Waterhouse in Chicago and Toledo, OH and he is a current member of the AICPA and the Financial Executives Institute.

Tord B. Lendau became a director of the Company in June 2001. Mr. Lendau is the General Manager of Sandvik MedTec AB, a Contract Manufacturer within medical devices. From 1998 to 2001, Mr. Lendau was President of Noster Systems AB, a medical device company developing a system to detect the bacteria that causes stomach ulcers. From 1997 to 1998, he acted as president of ArthroCare Europe AB, overseeing the start-up of its international operations. Mr. Lendau was vice president and general manager of Medtronic/Synectics from 1996 to 1997 after the acquisition of Synectics Medical AB by Medtronic, Inc. Prior to this acquisition, from 1991 to 1996, Mr. Lendau was the CEO of Synectics Medical AB, a Swedish public company. Mr. Lendau studied in M.Sc. at Link�ping University.